Extent of resection influences outcomes for patients with gliomas
In recent years, advances in our understanding of the biology of low-grade gliomas (LGG) and high-grade gliomas (HGG) have driven new paradigms in molecular markers, diagnostic imaging, operative techniques and technologies, and adjuvant therapies. Taken together, these developments are collectively...
Gespeichert in:
| Veröffentlicht in: | Revue neurologique 2011-10, Vol.167 (10), p.648-654 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 654 |
|---|---|
| container_issue | 10 |
| container_start_page | 648 |
| container_title | Revue neurologique |
| container_volume | 167 |
| creator | Sanai, N. Berger, M.S. |
| description | In recent years, advances in our understanding of the biology of low-grade gliomas (LGG) and high-grade gliomas (HGG) have driven new paradigms in molecular markers, diagnostic imaging, operative techniques and technologies, and adjuvant therapies. Taken together, these developments are collectively pushing the envelope towards improved quality of life and survival. Here, we review the recent literature to synthesize a comprehensive review of the value of extent of resection for LGGs and HGGs in the modern neurosurgical era.
Les progrès de ces dernières années dans la biologie des gliomes de bas et haut grade de malignité ont conduit à développer de nouveaux paradigmes dans l’imagerie diagnostique, les techniques et technologies opératoires et les traitements adjuvants. Toutes ces avancées contribuent à améliorer la qualité de vie et la survie des patients. Cet article est une revue générale consacrée à la valeur de l’étendue de la résection des gliomes de bas et haut grade à l’ère de la neurochirurgie moderne. |
| doi_str_mv | 10.1016/j.neurol.2011.07.004 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_895855049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0035378711003031</els_id><sourcerecordid>895855049</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-e1d301bc29d6e06cfad9edd0d36e356525567f2fb2744617dc38612614ad1f893</originalsourceid><addsrcrecordid>eNp90LtOwzAUgGEPIFoKb4BQFsSUcGwnTrIgVVW5SEgsMFuufQyukrjYCZe3J1ULbEz28J1j6yfkjEJGgYqrddbhEHyTMaA0gzIDyA_IFIAXKS-rckKOY1wDMFoCPyITRmvgjOdTMl9-9tj1ibdJwIi6d75LXGebATuNMfFDr307XqwPyUb1bsQx-XD9a_LSON-qeEIOrWoinu7PGXm-WT4t7tKHx9v7xfwh1bymfYrUcKArzWojEIS2ytRoDBgukBeiYEUhSsvsipV5LmhpNK8EZYLmylBb1XxGLnd7N8G_DRh72bqosWlUh36IsqqLqigg38p8J3XwMQa0chNcq8KXpCC3veRa7nrJbS8JpRx7jWPn-weGVYvmd-gn1ggu9kBFrRobVKdd_HO5YKJmbHTXO4djjneHQUbttjmNC2Nhabz7_yffKyCM3Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>895855049</pqid></control><display><type>article</type><title>Extent of resection influences outcomes for patients with gliomas</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sanai, N. ; Berger, M.S.</creator><creatorcontrib>Sanai, N. ; Berger, M.S.</creatorcontrib><description>In recent years, advances in our understanding of the biology of low-grade gliomas (LGG) and high-grade gliomas (HGG) have driven new paradigms in molecular markers, diagnostic imaging, operative techniques and technologies, and adjuvant therapies. Taken together, these developments are collectively pushing the envelope towards improved quality of life and survival. Here, we review the recent literature to synthesize a comprehensive review of the value of extent of resection for LGGs and HGGs in the modern neurosurgical era.
Les progrès de ces dernières années dans la biologie des gliomes de bas et haut grade de malignité ont conduit à développer de nouveaux paradigmes dans l’imagerie diagnostique, les techniques et technologies opératoires et les traitements adjuvants. Toutes ces avancées contribuent à améliorer la qualité de vie et la survie des patients. Cet article est une revue générale consacrée à la valeur de l’étendue de la résection des gliomes de bas et haut grade à l’ère de la neurochirurgie moderne.</description><identifier>ISSN: 0035-3787</identifier><identifier>DOI: 10.1016/j.neurol.2011.07.004</identifier><identifier>PMID: 21903234</identifier><identifier>CODEN: RENEAM</identifier><language>eng</language><publisher>Paris: Elsevier Masson SAS</publisher><subject>Biological and medical sciences ; Biomarkers, Tumor ; Brain Neoplasms - pathology ; Brain Neoplasms - surgery ; Cell Transformation, Neoplastic ; Chemoradiotherapy, Adjuvant ; Combined Modality Therapy ; Extent of resection ; Glioma ; Glioma - pathology ; Glioma - surgery ; Gliome ; Humans ; Magnetic Resonance Imaging ; Medical sciences ; Microchirurgie ; Microsurgical resection ; Neural Pathways - pathology ; Neurology ; Neurosurgical Procedures ; Prognosis ; Résection chirurgicale ; Treatment Outcome ; Tumors of the nervous system. Phacomatoses</subject><ispartof>Revue neurologique, 2011-10, Vol.167 (10), p.648-654</ispartof><rights>2011</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011. Published by Elsevier Masson SAS.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-e1d301bc29d6e06cfad9edd0d36e356525567f2fb2744617dc38612614ad1f893</citedby><cites>FETCH-LOGICAL-c391t-e1d301bc29d6e06cfad9edd0d36e356525567f2fb2744617dc38612614ad1f893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0035378711003031$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24626922$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21903234$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sanai, N.</creatorcontrib><creatorcontrib>Berger, M.S.</creatorcontrib><title>Extent of resection influences outcomes for patients with gliomas</title><title>Revue neurologique</title><addtitle>Rev Neurol (Paris)</addtitle><description>In recent years, advances in our understanding of the biology of low-grade gliomas (LGG) and high-grade gliomas (HGG) have driven new paradigms in molecular markers, diagnostic imaging, operative techniques and technologies, and adjuvant therapies. Taken together, these developments are collectively pushing the envelope towards improved quality of life and survival. Here, we review the recent literature to synthesize a comprehensive review of the value of extent of resection for LGGs and HGGs in the modern neurosurgical era.
Les progrès de ces dernières années dans la biologie des gliomes de bas et haut grade de malignité ont conduit à développer de nouveaux paradigmes dans l’imagerie diagnostique, les techniques et technologies opératoires et les traitements adjuvants. Toutes ces avancées contribuent à améliorer la qualité de vie et la survie des patients. Cet article est une revue générale consacrée à la valeur de l’étendue de la résection des gliomes de bas et haut grade à l’ère de la neurochirurgie moderne.</description><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor</subject><subject>Brain Neoplasms - pathology</subject><subject>Brain Neoplasms - surgery</subject><subject>Cell Transformation, Neoplastic</subject><subject>Chemoradiotherapy, Adjuvant</subject><subject>Combined Modality Therapy</subject><subject>Extent of resection</subject><subject>Glioma</subject><subject>Glioma - pathology</subject><subject>Glioma - surgery</subject><subject>Gliome</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Medical sciences</subject><subject>Microchirurgie</subject><subject>Microsurgical resection</subject><subject>Neural Pathways - pathology</subject><subject>Neurology</subject><subject>Neurosurgical Procedures</subject><subject>Prognosis</subject><subject>Résection chirurgicale</subject><subject>Treatment Outcome</subject><subject>Tumors of the nervous system. Phacomatoses</subject><issn>0035-3787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90LtOwzAUgGEPIFoKb4BQFsSUcGwnTrIgVVW5SEgsMFuufQyukrjYCZe3J1ULbEz28J1j6yfkjEJGgYqrddbhEHyTMaA0gzIDyA_IFIAXKS-rckKOY1wDMFoCPyITRmvgjOdTMl9-9tj1ibdJwIi6d75LXGebATuNMfFDr307XqwPyUb1bsQx-XD9a_LSON-qeEIOrWoinu7PGXm-WT4t7tKHx9v7xfwh1bymfYrUcKArzWojEIS2ytRoDBgukBeiYEUhSsvsipV5LmhpNK8EZYLmylBb1XxGLnd7N8G_DRh72bqosWlUh36IsqqLqigg38p8J3XwMQa0chNcq8KXpCC3veRa7nrJbS8JpRx7jWPn-weGVYvmd-gn1ggu9kBFrRobVKdd_HO5YKJmbHTXO4djjneHQUbttjmNC2Nhabz7_yffKyCM3Q</recordid><startdate>20111001</startdate><enddate>20111001</enddate><creator>Sanai, N.</creator><creator>Berger, M.S.</creator><general>Elsevier Masson SAS</general><general>Masson</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20111001</creationdate><title>Extent of resection influences outcomes for patients with gliomas</title><author>Sanai, N. ; Berger, M.S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-e1d301bc29d6e06cfad9edd0d36e356525567f2fb2744617dc38612614ad1f893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor</topic><topic>Brain Neoplasms - pathology</topic><topic>Brain Neoplasms - surgery</topic><topic>Cell Transformation, Neoplastic</topic><topic>Chemoradiotherapy, Adjuvant</topic><topic>Combined Modality Therapy</topic><topic>Extent of resection</topic><topic>Glioma</topic><topic>Glioma - pathology</topic><topic>Glioma - surgery</topic><topic>Gliome</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Medical sciences</topic><topic>Microchirurgie</topic><topic>Microsurgical resection</topic><topic>Neural Pathways - pathology</topic><topic>Neurology</topic><topic>Neurosurgical Procedures</topic><topic>Prognosis</topic><topic>Résection chirurgicale</topic><topic>Treatment Outcome</topic><topic>Tumors of the nervous system. Phacomatoses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sanai, N.</creatorcontrib><creatorcontrib>Berger, M.S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Revue neurologique</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sanai, N.</au><au>Berger, M.S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extent of resection influences outcomes for patients with gliomas</atitle><jtitle>Revue neurologique</jtitle><addtitle>Rev Neurol (Paris)</addtitle><date>2011-10-01</date><risdate>2011</risdate><volume>167</volume><issue>10</issue><spage>648</spage><epage>654</epage><pages>648-654</pages><issn>0035-3787</issn><coden>RENEAM</coden><abstract>In recent years, advances in our understanding of the biology of low-grade gliomas (LGG) and high-grade gliomas (HGG) have driven new paradigms in molecular markers, diagnostic imaging, operative techniques and technologies, and adjuvant therapies. Taken together, these developments are collectively pushing the envelope towards improved quality of life and survival. Here, we review the recent literature to synthesize a comprehensive review of the value of extent of resection for LGGs and HGGs in the modern neurosurgical era.
Les progrès de ces dernières années dans la biologie des gliomes de bas et haut grade de malignité ont conduit à développer de nouveaux paradigmes dans l’imagerie diagnostique, les techniques et technologies opératoires et les traitements adjuvants. Toutes ces avancées contribuent à améliorer la qualité de vie et la survie des patients. Cet article est une revue générale consacrée à la valeur de l’étendue de la résection des gliomes de bas et haut grade à l’ère de la neurochirurgie moderne.</abstract><cop>Paris</cop><pub>Elsevier Masson SAS</pub><pmid>21903234</pmid><doi>10.1016/j.neurol.2011.07.004</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0035-3787 |
| ispartof | Revue neurologique, 2011-10, Vol.167 (10), p.648-654 |
| issn | 0035-3787 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_895855049 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Biological and medical sciences Biomarkers, Tumor Brain Neoplasms - pathology Brain Neoplasms - surgery Cell Transformation, Neoplastic Chemoradiotherapy, Adjuvant Combined Modality Therapy Extent of resection Glioma Glioma - pathology Glioma - surgery Gliome Humans Magnetic Resonance Imaging Medical sciences Microchirurgie Microsurgical resection Neural Pathways - pathology Neurology Neurosurgical Procedures Prognosis Résection chirurgicale Treatment Outcome Tumors of the nervous system. Phacomatoses |
| title | Extent of resection influences outcomes for patients with gliomas |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A19%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extent%20of%20resection%20influences%20outcomes%20for%20patients%20with%20gliomas&rft.jtitle=Revue%20neurologique&rft.au=Sanai,%20N.&rft.date=2011-10-01&rft.volume=167&rft.issue=10&rft.spage=648&rft.epage=654&rft.pages=648-654&rft.issn=0035-3787&rft.coden=RENEAM&rft_id=info:doi/10.1016/j.neurol.2011.07.004&rft_dat=%3Cproquest_cross%3E895855049%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=895855049&rft_id=info:pmid/21903234&rft_els_id=S0035378711003031&rfr_iscdi=true |